One thing I keep seeing online is people panicking when hunger starts to return on a GLP-1 medication. The assumption is usually that the medication stopped working or that something has gone wrong metabolically.
But I think a lot of that panic comes from how oversimplified the public conversation around these medications has become.
GLP-1s are often discussed like they are just appetite suppressants. So people understandably assume that if they feel hungry again, the treatment must be failing. But obesity medicine specialists and researchers talk about these medications in a much more nuanced way than that.
These medications affect satiety signaling, reward pathways, insulin resistance, gastric emptying, blood sugar regulation, and brain signaling connected to food intake and energy regulation. That is part of why so many patients describe the experience as feeling “different” around food, not simply less hungry.
Hunger and Satiety Are Not the Same Thing
I think one of the most important distinctions people miss is the difference between hunger and satiety. Hunger is a biological signal that your body needs energy. Satiety is your body’s ability to recognize that it has had enough.
For many people living with obesity or metabolic dysfunction, that regulation system may not function typically. That is something obesity medicine experts discuss frequently, but it often gets lost online where everything gets reduced to “eat less” or “just stay in a calorie deficit.”
A lot of patients are not simply struggling with hunger. They are struggling with impaired fullness signaling, persistent cravings, reward seeking behavior around food, and constant mental preoccupation with eating.
What Patients Mean When They Talk About “Food Noise”
From my perspective as both a patient and an obesity care advocate who regularly interviews obesity medicine physicians and researchers on The Plus SideZ Podcast, one of the most consistent things I hear is patients describing relief from food noise.
The constant intrusive thoughts about food quiet down. The urgency around eating changes. People often describe finally feeling satisfied after meals instead of continuing to chase fullness. That is very different from simply “not being hungry.”
And honestly, I think this is one of the reasons these medications can feel so emotionally significant for patients. Many people realize for the first time that what they were experiencing was not simply a lack of discipline or willpower.
Hunger Returning May Not Mean Failure
Over time, the experience on these medications can evolve. Early in treatment, some people may have very little appetite at all. Later, hunger may return in a more normal way while satiety, portion control, and reduced food noise remain improved compared to before treatment. That does not necessarily indicate treatment failure.
I think social media sometimes creates unrealistic expectations where people start believing the goal is to never feel hunger again. But hunger itself is normal biology. The more important question is whether the underlying dysregulation around satiety, cravings, compulsive eating patterns, and food noise has improved.
Obesity Is More Complex Than Public Conversations Suggest
Obesity is a complex chronic, progressive disease involving hormones, metabolism, brain signaling, genetics, environment, and energy regulation. GLP-1 medications are interacting with many of those systems simultaneously, which is why the patient experience is often far more nuanced than the simplified headlines people see online.
And honestly, I think patients deserve more conversations that reflect that complexity instead of reducing everything to “they make you not hungry.”
If you’re feeling more hunger on a GLP-1 to where are you feel cannot stay in a calorie deficit, talk to your doctor about possibly increasing the medication dose or adding in another anti obesity medication like Contrave or Qsymia.
Follow The Plus SideZ Podcast anywhere you get your podcasts
